JEMEZGO
Live / Applied — First extension granted (statement of use) (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 04 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99318915
- Mark type
- Stylized text
- Filed
- 04 Aug 2025
- Published for opposition
- 20 Jan 2026
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
Owner
- Celgene Corporation, Princeton, NJ, US
- Celgene Corporation, Princeton, NJ, US
Prosecution history
- 10 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2026 — SOU EXTENSION 1 GRANTED
- 09 Sept 2026 — SOU EXTENSION 1 FILED
- 09 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jan 2026 — PUBLISHED FOR OPPOSITION
- 14 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Dec 2025 — ASSIGNED TO EXAMINER
- 11 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 04 Aug 2025 — NEW APPLICATION ENTERED